Brief: Innoviva Sells 15% Economic Stake In Theravance Respiratory Co To Royalty Pharma For Approximately $282 Mln Plus Full Ownership Of Existing Equity Investments, The Potential For $50 Mln Milestone Payment

Innoviva

13/07/2022 21:34

July 13 (Reuters) - Innoviva Inc  INVA.O :
    * INNOVIVA SELLS 15% ECONOMIC STAKE IN THERAVANCE
RESPIRATORY
COMPANY TO ROYALTY PHARMA FOR APPROXIMATELY $282 MILLION PLUS
FULL OWNERSHIP OF EXISTING EQUITY INVESTMENTS AND THE POTENTIAL
FOR $50 MILLION MILESTONE PAYMENT
    * INNOVIVA INC - TO RECEIVE APPROXIMATELY $282 MILLION IN
CASH UP
FRONT WITH POTENTIAL $50 MILLION MILESTONE PAYMEN
    * INNOVIVA INC - INNOVIVA TO RETAIN TRC'S FULL OWNERSHIP IN
ATTRACTIVE PRIVATE INVESTMENTS

Source text for Eikon:  ID:nBw8Rj1QRa 
Further company coverage:  INVA.O